return unused medication to a pharmacist Active Ingredient Semaglutide 3mg Drug Class GLP-1 Receptor Agonist (Glucagon-like Peptide-1 Receptor Agonist) Formulation Film-coated oral tablet Manufacturer Novo Nordisk A/S Excipients Sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC), microcrystalline cellulose, hydroxypropylcellulose, magnesium stearate, polyvinyl alcohol, polyethylene glycol, titanium dioxide Rybelsus 3mg may cause side effects in some individuals
Patients should be aware that tirzepatide may reduce the effectiveness of oral contraceptives during dose escalation
The overall safety and tolerability profile of orforglipron in ATTAIN-MAINTAIN was consistent with previous orforglipron Phase 3 studies
The mechanisms might involve neuroprotection, reduced inflammation, and improved energy metabolism in the brain
Older individuals produce by a lot less glutathione, which creates increased oxidative stress and cellular damage